Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients

AstraZeneca · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
biomarkersbreastcancerpharmacokinetics
fgfr inhibition, pharmacokinetics, biomarkers, er+ breast cancer, breast cancer, er+, fgfr1, exemestane, azd4547, fulvestrant, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 980865
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.